These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37864455)

  • 1. Refractory atypical IgA pemphigus successfully treated with apremilast.
    Zhou Y; Xiao Y; Wang Y; Li W
    J Dermatol; 2024 Mar; 51(3):e86-e87. PubMed ID: 37864455
    [No Abstract]   [Full Text] [Related]  

  • 2. Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris.
    Meier K; Holstein J; Solimani F; Waschke J; Ghoreschi K
    Front Immunol; 2020; 11():588315. PubMed ID: 33193415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer.
    Cetkovská P; Komorousová M; Lomicová I
    Dermatol Ther; 2014; 27(4):236-9. PubMed ID: 24754245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
    Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
    Cunha PR; de Oliveira JR; Salles MJ; Jamora J; Bystryn JC
    Int J Dermatol; 2004 Sep; 43(9):682-4. PubMed ID: 15357753
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay: a case report and review of the literature.
    Zaraa I; Kerkeni N; Sellami M; Chelly I; Zitouna M; Makni S; Mokni M; Ben Osman A
    Int J Dermatol; 2010 Mar; 49(3):298-302. PubMed ID: 20465668
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
    Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
    J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of refractory Hailey-Hailey disease with apremilast.
    Di Altobrando A; Sacchelli L; Patrizi A; Bardazzi F
    Clin Exp Dermatol; 2020 Jul; 45(5):604-605. PubMed ID: 31930532
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.
    Koga H; Tsutsumi M; Teye K; Ishii N; Yamaguchi M; Nagafuji K; Nakama T
    J Dermatol; 2023 Feb; 50(2):234-238. PubMed ID: 35838241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus.
    Hisamatsu Y; Amagai M; Garrod DR; Kanzaki T; Hashimoto T
    Br J Dermatol; 2004 Jul; 151(1):73-83. PubMed ID: 15270874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against desmocollins in European patients with pemphigus.
    Müller R; Heber B; Hashimoto T; Messer G; Müllegger R; Niedermeier A; Hertl M
    Clin Exp Dermatol; 2009 Dec; 34(8):898-903. PubMed ID: 19456767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile IgA pemphigus: A case report and review of literature.
    Neethu KC; Rao R; Balachandran C; Pai S
    Indian J Dermatol Venereol Leprol; 2016; 82(4):439-42. PubMed ID: 27279313
    [No Abstract]   [Full Text] [Related]  

  • 13. IgA/IgG pemphigus with infiltration of neutrophils and eosinophils in an ulcerative colitis patient.
    Uchiyama R; Ishii N; Arakura F; Kiniwa Y; Nakazawa K; Uhara H; Hashimoto T; Okuyama R
    Acta Derm Venereol; 2014 Nov; 94(6):737-8. PubMed ID: 24604005
    [No Abstract]   [Full Text] [Related]  

  • 14. Apremilast in benign chronic pemphigus (Hailey-Hailey disease).
    Riquelme-Mc Loughlin C; Iranzo P; Mascaró JM
    Clin Exp Dermatol; 2020 Aug; 45(6):737-739. PubMed ID: 32198945
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of IgG/IgA pemphigus presenting malar rash-like erythema.
    Hosoda S; Suzuki M; Komine M; Murata S; Hashimoto T; Ohtsuki M
    Acta Derm Venereol; 2012 Mar; 92(2):164-6. PubMed ID: 22113238
    [No Abstract]   [Full Text] [Related]  

  • 16. Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus.
    Manjaly P; Sanchez K; Gregoire S; Ly S; Kamal K; Mostaghimi A
    Dermatol Clin; 2024 Apr; 42(2):307-315. PubMed ID: 38423689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory IgA pemphigus successfully managed with adalimumab as monotherapy.
    Lluch-Galcerá JJ; Alcoverro C; Prat E; Martinez-Molina M; Bielsa I; Quer A; Bassas J
    J Dtsch Dermatol Ges; 2023 Dec; 21(12):1560-1562. PubMed ID: 37875783
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic retinoids for treatment of recalcitrant IgA pemphigus.
    Schauer F; Kern JS; Kiritsi D
    Orphanet J Rare Dis; 2018 Sep; 13(1):163. PubMed ID: 30227880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of subcorneal pustular type of IgA pemphigus].
    Raap U; Völker B; Petering H; Hashimoto T; Zillikens D; Kapp A; Werfel T
    Hautarzt; 2005 Jan; 56(1):66-70. PubMed ID: 15580453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beneficial effect of thalidomide in a case of Hailey-Hailey pemphigus. 1 years' trial].
    Schnitzler L
    Ann Dermatol Venereol; 1984; 111(3):285-6. PubMed ID: 6732126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.